(via TheNewswire)

VANCOUVER, British Columbia, JUNE 8, 2026 - TheNewswire – Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) (“Noveris” or the “Company”) is pleased to announce the appointment of Geoff Griffiths as Strategic Advisor to the Company.

Mr. Griffiths is a seasoned life sciences executive with more than 25 years of experience spanning the pharmaceutical, biotechnology, and technology sectors. Throughout his career, he has held senior leadership roles across commercialization, market access, business development, strategic planning, operations, investor relations, and product development.

In his advisory capacity, Mr. Griffiths will work with management and the Board to evaluate opportunities related to intellectual property strategy, commercialization initiatives, licensing opportunities, strategic partnerships, and broader corporate development activities.

Mr. Griffiths currently serves as Head of Operations at Shackelford Pharma, where he has led the strategic and operational development of a neurology-focused drug candidate from inception through Phase 2 readiness. He is also Principal of G3 Strategic Consulting, advising growth-stage companies on commercialization strategy, financial analysis, business planning, and market development. Previously, he held leadership positions with Mylan Pharmaceuticals and Abbott Laboratories, where he was responsible for commercial strategy, market access, sales leadership, and biosimilar development initiatives across Canada.

Jason Birmingham, Chief Executive Officer of Noveris, commented:

“Geoff brings a rare combination of commercial, operational, and strategic experience developed across both large pharmaceutical organizations and emerging growth companies. His background in commercialization, market development, and value creation will provide meaningful perspective as we assess opportunities to build long-term shareholder value.”

Mr. Griffiths commented:

“Noveris has assembled a compelling portfolio of intellectual property and scientific assets. I am excited to work with management and the Board as the Company evaluates opportunities to advance its strategic objectives, develop partnerships, and pursue commercialization pathways that can create sustainable value over time.”

ABOUT NOVERIS HEALTH SCIENCES INC.

Noveris Health Sciences Inc. is a biotechnology company focused on the development, advancement, and commercialization of intellectual property, technologies, and therapeutic opportunities addressing significant unmet needs in healthcare. The Company continues to evaluate opportunities to create value through strategic partnerships, licensing arrangements, research collaborations, and related commercial initiatives.

ON BEHALF OF THE BOARD OF DIRECTORS

NOVERIS HEALTH SCIENCES INC.

Jason Birmingham

Chief Executive Officer

For further information

Noveris Health Sciences Inc.

Tel: +1 778-900-NVRS (6877)

Email: fair@noveris.health

Web:www.noveris.health

FORWARD-LOOKING STATEMENTS

This news release contains forward-looking statements within the meaning of applicable securities laws, including statements regarding the anticipated contributions of Mr. Griffiths, the Company’s intellectual property strategy, commercialization initiatives, licensing opportunities, strategic partnerships, corporate development activities, and future business plans. Forward-looking statements are based on management’s current expectations, estimates, projections, and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Readers are cautioned not to place undue reliance on forward-looking statements. Except as required by applicable securities laws, the Company undertakes no obligation to update or revise any forward-looking statements.

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release.

Copyright (c) 2026 TheNewswire - All rights reserved.